loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 203911 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 FLUDEOXYGLUCOSE F-18 (1)

filter

01 NUKEMED (1)

filter

01 INJECTABLE;INTRAVENOUS (1)

filter

01 4-500mCi/ML (1)

filter

01 USA (1)

URL Supplier Web Content
INJECTABLE;INTRAVENOUS
4-500mCi/ML
FLUDEOXYGLUCOSE F18
USA
203911
2015-04-22
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 203911

Looking for CTD TGA MCC DOSSIER APPLICATION 203911 1

19

Nukemed, based in U.S.A, is a pharmaceutical company.

One of their notable products is FLUDEOXYGLUCOSE F-18, with a corresponding application number 203911 and regulatory information .

proudly manufactured in the

approval since 2015-04-22

Nukemed's FLUDEOXYGLUCOSE F18 INJECTABLE;INTRAVENOUS, medication with 4-500mCi/ML of FLUDEOXYGLUCOSE F-18.

Post Enquiry
POST ENQUIRY